Compare Nebius Group NV (NBIS) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nebius Group NV vs 10X Genomics Inc — how do they compare? Nebius Group NV trades at $217.21 (market cap $49.06B), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: Nebius Group NV is far larger — about 6.4× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals.
| NBIS | TXG | |
|---|---|---|
Market Cap | $49.06B | $7.61B |
Sector | Technology | Health |
52-Week High | $286.69 | $58.57 |
52-Week Low | $64.06 | $11.34 |
Enterprise Value | $49.26B | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
